Michael Ronellenfitsch

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant

AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment

Advancing sarcoma diagnostics with expanded DNA methylation-based classification

Optimized Long‐<scp>TE ¹H sLASER MR</scp> Spectroscopic Imaging at <scp>3T</scp> for Separate Quantification of Glutamate and Glutamine in Glioma

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients

Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review

<scp>2D ¹H sLASER</scp> Long‐<scp>TE</scp> and <scp>3D ³¹P</scp> Chemical Shift Imaging at 3 T for Monitoring Fasting‐Induced Changes in Brain Tumor Tissue

An AMP‐activated protein kinase‐PGC‐1α axis mediates metabolic plasticity in glioblastoma

Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients

Formate promotes invasion and metastasis in reliance on lipid metabolism

Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas

Histologische und molekularpathologische Besonderheiten von Tumoren des peripheren Nervensystems

Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients

The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients

Meningioma Surgery in Patients ≥70 Years of Age: Clinical Outcome and Validation of the SKALE Score

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy

BSCI-11. Targeting PI3K/Akt/mTOR pathway to prevent melanoma brain metastasis

Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy

ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma

Serine-dependent redox homeostasis regulates glioblastoma cell survival

Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death

Linking epigenetic signature and metabolic phenotype in <i>IDH</i> mutant and <i>IDH</i> wildtype diffuse glioma

Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas

Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems